Chemical modification of histidine residues in castor bean hemagglutinin (CBH) with diethylpyrocarbonate (DEP) was studied with regard to saccharide binding. The analytical data clearly indicate that 6 out of 14 histidine residues in CBHare eventually modified with DEPat pH 6.1 in the absence of specific saccharides. Modification of histidine residues greatly decreased the cytoagglutination by CBH, and only 10%of the residual activity was found in the derivative of CBHin which 2 histidine residues/mol were ethoxyformylated. Upon binding with galactose, the modified CBHcontaining 2 ethoxyformyl histidine/mol displayed an UV-difference spectrum with a maximumat 291 nm owing to the red shift of tryptophan, similar to native CBH,but its ability to bind galactose was one-fourth that of native CBH. On binding with galactopyranosides, the number of histidine residues eventually modified with DEPdecreased by 2 per molecule, and the cytoagglutinating activity was retained.
Hydroxylamine removed the ethoxyformyl groups from the inactive derivative of CBH which contained 6 ethoxyformyl histidine/mol, restoring the saccharide-binding ability. The results suggest that in the saccharide-binding site on each B-chain of CBH,there exists a histidine residue essential for interaction with a galactopyranosyl residue at the non-reducing end of saccharides.
Castor bean hemagglutinin (CBH) from Ricinus communis seeds is a relatively nontoxic but hemagglutinating protein and consists of two sets of polypeptide chains (A-and B-chains).
The A-and B-chains are linked through a single disulfide bond and two A-B units are associated by a noncovalent bond to form a dimer with an apparant molecular weight of 130,000^'2) This is a lectin that binds galactopyranosides specifically. 3'4) The binding of CBH to the galactose-containing receptor on the cell membrane is the first and obligatory step for eliciting cytoagglutination, and this binding is served by two B-chains.1]
The interaction of CBH with its specific saccharides has been analyzed by equilibrium dialysis5) and spectroscopy.6) From the UVdifference spectroscopic analysis for binding of 735 various saccharides to CBH, we have postulated that the saccharide-binding site of CBH has a subsite structure capable of interacting with oligosaccharides and there is a tryptophan residue at or near the saccharidebinding site.6) Chemical modification and spectroscopic studies on CBHhave suggested that Trp131 on each B-chain is important for saccharide binding of CBH and it may be at one of the subsites with which a glucopyranosyl-fructofuranosyl moiety of the raffinose molecule interacts.7~9) Thus, data concerning the role of tryptophan residues in the function of CBHhas been accumulated, but there is a little data to explain the role of other amino acids involved in the saccharidebinding site of CBH. In a search for amino acid residues responsible for saccharide bind- were recorded with a Hitachi 200-10 spectrophotometer with a thermostatted cell holder.
Modification of CBHwith DEP. The modification reaction was done in a quartz cell with 1 cm path length at 20°C. Threeml of the CBH solution (5.1 im) in the buffer at a given pH was placed in the sample and reference cells.
To the sample and reference cells were added 0.1 ml of DEPor the same volume of the buffer solution, and the difference spectra were recorded at various times. The final concentration of DEPin the reaction mixture was 0.25mM, and the number of histidine residues modified was calculated using a molar extinction value for N'ethoxyformyl histidine of 3,200cm^M"1 at 240nm.ll) Cytoagglutinating activity. Cytoagglutinating activity of CBHwas measured microscopically using Sarcoma 180 ascites tumor cells in 5 mMphosphate buffered saline at pH 7.1, as described by Funatsu et al.12) For assay of the cytoagglutinating activity of the modified CBH, samples were withdrawn from the reaction mixture at times, diluted with 100 volumes ofdeionized water and dialyzed against the above buffer at 4°C.
Hydroxylamine treatment. After completion of the modification reaction at pH 6.1, an inactive derivative of CBH, in which 6 histidine residues/mol were ethoxyformylated, was treated with 0.2m hydroxylamine at 20°C. The hydroxylamine solution was adjusted to pH 6.1 with KOHbefore the addition to the reaction mixture.
UV-difference spectra of CBHand its derivative induced by binding with galactose. UV-difference spectra of CBH and modified CBHproduced by binding with galactose were measured at pH7.0 and 25°C and the association constants for binding of galctose to proteins were calculated by Scatchard plots as previously reported.6)
Results
Accessibility of histidine residues in CBHto DEP Figure 1 shows an UV-difference spectrum of the DEP-treated CBH versus untreated CBH. The spectrum has a maximumat 240 nm, owing to the formation of N'-ethoxyformyl histidine, 13) while no noticeable absorption change is observed at 280~300nm.' The magnitude of the difference maximum at 240nm increased with the progress of the incubation time and reached a plateau (inset in Fig. 1 ). From the variation of the intensity at 240nm, the number of histidine residues modified with DEP was calculated and plotted as a function of the incubation time. In the absence of saccharide, 6 histidine residues/mol were eventually ethoxyformylated at pH 6.1 and 20°C, as shown in Fig. 2 . The same result was obtained whenthe modifi- cation reaction was done at pH 7.0 (data not shown). However, 4 histidine residues/mol were modified with DEPin the presence of galactose, a potent ligand for CBH.4'6) Similar results were obtained whenother specific saccharides such as lactose and raffinose were used in place of galactose, indicating that 2 histidine residues/mol were protected from this modification reaction in the CBH-saccharide complexes. Such a protective effect, however, was not found when lactose was added at the point where 2 histidine residues/mol were modified in the absence of saccharide. These results indicate that 2 histidine residues available for the reaction with DEP at the initial stage of the reaction are closely associated with the saccharide binding of CBH.
Effect of ethoxyformylation of histidine on cytoagglutinating activity
The cytoagglutinating activity of CBHtoward Sarcoma 180 ascites tumor cells de- Cytoagglutinating activities of CBH and its derivatives were assayed using Sarcoma 180 ascites tumor cells in 5mM phosphate buffered saline at pH 7.1 as described in the literature. 12) Samples modified with DEP at pH 6.1 were used for cytoagglutination tests, and the residual activities were plotted versus the number of histidine residues modified per molecule. The activity of native CBHwas taken to be 100%. creased markedly during the modification with DEP, as shown in Fig. 3 and Table I . Only 10% of the cytoagglutinating activity was retained after ethoxyformylation of 2 histidine residues/mol, but the subsequent loss of the residual activity was 5%. This indicates that the loss of the cytoagglutinating activity of CBHupon treatment with DEPis principally due to the modification of 2 histidine residue/mol. However, when the modification reaction was done in the presence of specific saccharides, the resulting derivatives of CBH which contained 4 ethoxyformylated histidine/mol retained more than 99% of the cytoagglutinating activity. These findings support the above view that in the CBHmolecule there are 2 histidine residues responsible for the interaction with saccharides.
Difference spectrum of ethoxyformylated CBH induced by binding with galactose
The UV-difference spectrum of the modified CBH induced by galactose is shown in Fig. 4 , compared with that of native CBH. Upon binding with galactose, the modified CBH, in which 2 histidine residues/mol were ethoxyfor- b Number of residues eventually modified under conditions cited. c Lactose was added at the point where 2 histidine residues/mol were modified with DEP in the absence of saccharide.
d The derivative ofCBH containing 6 N-ethoxyformyl histidine was treated with 0.2mM hydroxylamine at pH 6.1 and 20°C for 45min. mylated, displayed a difference spectrum with maxima at 284 and 291 nm owing to the red shift of tryptophan. The overall shape of the spectra given by CBHand its derivative were almost the same, but a larger amount of galactose was required to saturate the modified CBH (inset in Fig. 4) . By analyzing the change in the magnitude of the difference maximum at 291nm as a function of the galactose concentration, association constants (Ka) for binding of galactose to proteins were calculated by the method described previously.6)
The Ka values for CBHand the modified CBHwere found to be 7.9x lO3*!"1 and 2.2x 10~3M"~1, respectively, at pH 7.0 and 25°C, CBHwas incubated with DEP at pH 6.1 and 20°C as described in Fig. 1 . After 45min, 0.1ml of 6.4M hydroxylamine (adjusted to be pH 6.1 with KOH)was added both to sample and reference cells (final concentration 0.2 m), and the resulting solutions were further incubated at 20°C. Difference spectra were recorded at various times and the ethoxyformyl histidine contents calculated from the absorbance at 240nm were plotted against the incubation time.
Hydroxylamine treatment of the modified CBH Figure 5 demonstrates the change in the ethoxyformyl histidine content in the modified CBH during the hydroxylamine treatment.
When the modified CBH containing 6 ethoxyformyl histidine was incubated with 0.2 m hydroxylamine at pH 6.1 and 20°C, the ethoxyformyl histidine content, as estimated from the absorbance at 240 nm, decreased markedly and returned to the prior modification level after 45 min, and the cytoagglutinating activity wasregained completely (Table I ).
Discussion
The reactivity of DEP has been directed towards the preferentiaj modification of histidine residues in proteins.13~15) CBHcontains 14 histidine residues per molecule: 5 histidines in each A-chain and 2 histidines in each Bchain. 16 17) Spectroscopic data clearly indicate that 6 histidine residues/mol are eventually modified with DEP at pH 6.1 (Fig. 2) . Taking into account the fact that DEP reacts only with unprotonated imidazole groups,18) it is reasonable to consider that the imidazole groups of these histidine residues available for the reaction with DEPare ionized at pH 6.1. Since the number of histidine residues eventually modified with DEPis not altered with increasing the pH to 7.0, it can be deduced that other 8 histidine residues which remained unmodified even at pH 7.0 are buried in the interior of the protein molecule or held between the constituent polypeptide chains of CBH. In the cytoagglutinating test, only 10% of the cytoagglutinating activity was found in the modified CBH, in which 2 histidine residues were ethoxyformylated ( Fig. 4 and Table I ). UV-difference spectroscopic data also indicate that the affinity of CBH to galactose, expressed as the association constant, decreased markedly after modification of 2 histidine residues/mol.
It is noteworthy that in the complexes with specific saccharides, 2 histidine residues/mol were protected from the modification with retention of cytoagglutinating activity, but the addition of lactose to the 739 modified CBH containing 2 ethoxyformyl histidine/mol did not change the number of histidine residues eventually modified, and the cytoagglutinating activity was abrogated ( Fig.  2 and Table I ). These resuslts stroungly suggest that the loss of the saccharide-binding ability of CBHon treatment with DEPis due to the modification of 2 histidine residues/mol. Spectroscopic studies on CBHhave indicated that Trp131 on the B-chain is important in the interaction with saccharides at the subsite, and binding of specific saccharides to CBHalters its environment, generating the UV-difference spectra with maxima at 284 and 291 nm.7~9)
As demonstrated here, CBHstill retains the ability to generate the galactose-induced UVdifference spectrum after modification of 2 histidine residues/mol ( Fig. 4) , albeit with quite low binding to galactose. It is plausible that ethoxyformylation of CBHdoes not affect Trp131 on the subsite but reduces the binding ability of the site with which the galactopyranosyl residue at the non-reducing end of the saccharides would interact. This may be supported by the evidence which indicates that 2 histidine residues/mol are shielded from this modification reaction even when complexed with galactose. Considering that CBH is a divalent lectin,4) it can be postulated that in each binding site on each B-chain there is a histidine residue which is important in the interaction with the galactopyranosyl residue at the non-reducing end of saccharides.
